Our group is involved in the design and synthesis of chemical probes targeting human kinases involved in different diseases. Lipid Kinases (PI4K-beta & PKC) and SFKs (Fyn & Src) are under investigation for the discovery of broad-spectrum antiviral agents. Other kinases are being studied for the treatment of Parkinson (LRRK2) and Alzheimer (GSK-3beta, DYRK1A) diseases.
For further information feel free to contact Marco Radi